[1]
2025. Development and Validation of a Gradient RP-HPLC Method for Simultaneous Estimation of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir in Combined Pharmaceutical Formulation: Research Article. Journal of Pharma Insights and Research. 3, 1 (Feb. 2025), 252–260. DOI:https://doi.org/10.69613/0376xn95.